CASP3 and cancer: Using GRETTA, we identified 16 DepMap cancer cell lines harboring low protein expression of both CASP3 and CASP7 and 10 cancer cell lines with high expression of both CASP3 and CASP7 across 13 cancer types (Figs 7H and S7A).